Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Usana Health Sciences (USNA) Debt to Equity (2016 - 2026)

Usana Health Sciences (USNA) has disclosed Debt to Equity for 7 consecutive years, with $0.03 as the latest value for Q1 2026.

  • Quarterly Debt to Equity fell 39.24% to $0.03 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $0.03 through Jan 2026, down 39.24% year-over-year, with the annual reading at $0.03 for FY2026, 39.24% down from the prior year.
  • Debt to Equity for Q1 2026 was $0.03 at Usana Health Sciences, down from $0.04 in the prior quarter.
  • The five-year high for Debt to Equity was $0.04 in Q1 2025, with the low at $0.0 in Q4 2023.
  • Average Debt to Equity over 5 years is $0.02, with a median of $0.03 recorded in 2022.
  • The sharpest move saw Debt to Equity skyrocketed 2634.25% in 2024, then tumbled 39.24% in 2026.
  • Over 5 years, Debt to Equity stood at $0.03 in 2022, then crashed by 93.84% to $0.0 in 2023, then surged by 2634.25% to $0.04 in 2024, then rose by 0.44% to $0.04 in 2025, then tumbled by 39.51% to $0.03 in 2026.
  • According to Business Quant data, Debt to Equity over the past three periods came in at $0.03, $0.04, and $0.04 for Q1 2026, Q1 2025, and Q4 2024 respectively.